Mesa Laboratories, Inc.
NASDAQ Global SelectTotal Valuation
Mesa Laboratories, Inc. carries a market capitalization of 600.44M, placing it among publicly traded companies globally. Its enterprise value stands at 487.48M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 600.44M |
| Enterprise Value | 487.48M |
Valuation Ratios
Mesa Laboratories, Inc. trades at a trailing price-to-earnings ratio of 44.94.
| PE Ratio | 44.94 |
| PS Ratio | 2.63 |
| PB Ratio | N/A |
| P/TBV Ratio | N/A |
| P/FCF Ratio | 15.48 |
| P/OCF Ratio | 16.89 |
Enterprise Valuation
On an enterprise value basis, Mesa Laboratories, Inc. trades at an EV/EBITDA multiple of 14.65 and an EV/FCF ratio of 12.78. The EV/Sales ratio of 2.63 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 30.93 provides insight into valuation relative to core operating earnings.
| EV / Sales | 2.63 |
| EV / EBITDA | 14.65 |
| EV / EBIT | 30.93 |
| EV / FCF | 12.78 |
Financial Position
Mesa Laboratories, Inc. maintains a current ratio of 4.62, meaning it holds 4.6x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 318.19, indicating elevated leverage, while an interest coverage ratio of 4.11 demonstrates adequate ability to service its debt obligations.
| Current Ratio | 4.62 |
| Quick Ratio | 2.93 |
| Debt / Equity | 318.19 |
| Debt / EBITDA | N/A |
| Interest Coverage | 4.11 |
Financial Efficiency
Mesa Laboratories, Inc. posts a return on equity of 12.79 and a return on invested capital of 7.17.
| Return on Equity (ROE) | 12.79 |
| Return on Assets (ROA) | 5.01 |
| Return on Invested Capital (ROIC) | 7.17 |
| Return on Capital Employed (ROCE) | 9.86 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 5.47 |
Taxes
Over the trailing twelve months, Mesa Laboratories, Inc. has paid 2.76M in income taxes, reflecting an effective tax rate of 20.28.
| Income Tax | 2.76M |
| Effective Tax Rate | 20.28 |
Stock Price Statistics
Mesa Laboratories, Inc.'s stock has gained approximately 7.67859% over the past 52 weeks. The 50-day moving average sits at 98.38, while the 200-day moving average is 83.03.
| Beta (5Y) | N/A |
| 52-Week Price Change | 7.67859% |
| 50-Day Moving Average | 98.38 |
| 200-Day Moving Average | 83.03 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Mesa Laboratories, Inc. generated 185.41M in revenue and converted that into 10.85M in net income, yielding earnings per share of 1.95. EBITDA reached 33.28M, while operating income came in at 15.76M.
| Revenue | 185.41M |
| Gross Profit | 116.07M |
| Operating Income | 15.76M |
| Pretax Income | 13.61M |
| Net Income | 10.85M |
| EBITDA | 33.28M |
| EBIT | 15.76M |
| Earnings Per Share (EPS) | 1.95 |
Cash Flow
Mesa Laboratories, Inc. produced 28.87M in operating cash flow over the past twelve months. After subtracting -2.83M in capital expenditures, free cash flow totaled 26.04M - equivalent to 4.72 per share.
| Operating Cash Flow | 28.87M |
| Capital Expenditures | -2.83M |
| Free Cash Flow | 26.04M |
| FCF Per Share | 4.72 |
Margins
Mesa Laboratories, Inc. operates with a gross margin of 62.60, reflecting its pricing power and cost economics. The operating margin of 8.50 and net profit margin of 5.85 provide insight into operational efficiency.
| Gross Margin | 62.60 |
| Operating Margin | 8.50 |
| Pretax Margin | 7.34 |
| Profit Margin | 5.85 |
| EBITDA Margin | 17.95 |
Dividends & Yields
The company's payout ratio of 24.33 indicates the proportion of earnings distributed to shareholders.
| Dividend Per Share | 0.48 |
| Dividend Yield | N/A |
| Payout Ratio | 24.33 |
| Shareholder Yield | 5.35 |
| FCF Yield | 6.46 |
Scores
Mesa Laboratories, Inc. posts an Altman Z-Score of 4.26, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 4.26 |